Extract from our Nordic M&A Newsletter

Read more about our Nordic M&A Newsletter service including the M&A Portal and Private Equity Portfolio Tracker.
OssDsign to IPO on Nasdaq First North
May 24, 2019

Nasdaq has announced that the trading of OssDsign will be commenced today on Nasdaq First North in Stockholm. OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved Healing of bone defects. OssDsign reported sales of SEK 8.8m with EBIT of SEK -49m in 2017.

ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library. If you would like more insights on this deal or industry then send us an email at requests@nordicknowledgepartners.com